Springdale-based NOWDiagnostics Inc.'s single-drop blood test for the covid-19 antibody is now available nationwide through the American Pharmacists Association Foundation, the company said Monday.
The test is now part of the IMPACT Care Transformation Network.
"As has been demonstrated since the pandemic began, pharmacist-provided care is essential to the public health and well being of communities everywhere, and we believe this opportunity with NOWDiagnostics and the APhA Foundation presents another excellent way for pharmacists to serve their patients and communities," Benjamin M. Bluml, RPh, senior vice president of research and innovation at the American Pharmacists Association Foundation, said in a statement.
In late May, NOWDiagnostics gained emergency authorization from the FDA for its single-drop blood test. The company had been working on the test since February of 2020 and sought emergency authorization for about a year.
The test has been approved by the FDA for use in various locations, including pharmacies, clinics and hospital emergency rooms.